Yu, Yang
Bao, Wenfang
Li, Yandong
Gao, Yong
Chen, Jingde
Funding for this research was provided by:
National Natural Science Foundation of China (82160468)
Beijing Xisike Clinical Oncology Research Foundation (Y-HH202102-0001)
Specialty Feature Construction Project of Shanghai Pudong New Area Health Commission (PWZzb2022-08)
Article History
Received: 31 March 2026
Accepted: 9 July 2026
First Online: 16 July 2026
Declarations
Ethics approval and consent to participate: All procedures involving human participants were performed in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. This study was approved by the Ethics Committee of Shanghai East Hospital, School of Medicine, Tongji University, China (No. 2019tjdx45). Written informed consent was obtained from all participants.All animal experiments were carried out in accordance with the ARRIVE guidelines and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The animal study protocol was approved by the Animal Ethics Committee of Tongji University (No. TJ-HB-LAC-2025-75).
Competing interests: The authors declare no competing interests.